$18.67
0.422.3%
Last update: Nov 9, 4:00 PM
City Therapeutics Inc (CTY) Stock Price, Quote, News & History
CTYNASDAQ
You can purchase shares of City Therapeutics (NASDAQ:CTY) through any online brokerage.
Other companies in City Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
City Therapeutics has a consensus price target of $34.00.
The stock price for City Therapeutics (NASDAQ: CTY) is $18.67 last updated November 9, 2026 at 4:00 PM EST.
There are no upcoming dividends for City Therapeutics.
City Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for City Therapeutics.
City Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
City Therapeutics Inc is a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics designed to silence the expression of disease-relevant proteins. Its current pipeline is focused on indications...
